Effects of a NeuroAD System, for the Treatment of Alzheimer Disease

NCT02166827 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Administrative decision

Conditions

Alzheimer's Disease

Interventions

DEVICE: NeuroAD
DEVICE: Sham TMS+Cog

Sponsor

Neuronix Ltd